e-Drug3D 1571 |
APIXABAN
|
cas 503612-47-3 |
CLASS BLOOD |
ROUTE (list) ORAL |
ATC code |
PK parameters F 50 PERCENT Solubility AQUEOUS SOLUBILITY ACROSS THE PHYSIOLOGICAL PH RANGE IS 0.04 MILLIGRAM / MILLILITER |
Target TARGET FACTOR XA PDB Ligand code = GG2 (link to the list of PDB complexes) Download experimental 3D coordinates of GG2 with added hydrogens |
DrugCentral Coagulation factor X UNIPROT P00742 F10 |
Download SDF file | 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4c]pyridine-3-carboxamide Formula: Calculated chemical properties: MW 459.50 NB_atoms 34 XLogP 2.70 PSA 102.756 NB_HD 2 NB_HA 9 fsp3 0.28 Lipinski(0=no;1=yes) 1 |
FDA NDA 202155 (label) INN (APIXABAN) ELIQUIS (BRISTOL MYERS SQUIBB) APPROVAL= AP YEAR= 2012 NDA 209944 (pdf not found) INN (APIXABAN) APIXABAN (SUNSHINE LAKE) APPROVAL= TA YEAR= 2019 NDA 210013 (pdf not found) INN (APIXABAN) APIXABAN (MICRO LABS) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 210128 (pdf not found) INN (APIXABAN) APIXABAN (MYLAN) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 210171 (pdf not found) INN (APIXABAN) APIXABAN (SUN PHARM INDUSTRIES) APPROVAL= TA YEAR= 2019 NDA 210152 (pdf not found) INN (APIXABAN) APIXABAN (BIONPHARMA) APPROVAL= AP YEAR= 2020 DISCONTINUED NDA 209898 (pdf not found) INN (APIXABAN) APIXABAN (INDOCO) APPROVAL= AP YEAR= 2020 NDA 210180 (pdf not found) INN (APIXABAN) APIXABAN (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2020 NDA 210082 (pdf not found) INN (APIXABAN) APIXABAN (DR REDDYS LABS INC) APPROVAL= TA YEAR= 2020 NDA 210142 (pdf not found) INN (APIXABAN) APIXABAN (TEVA PHARMS USA INC) APPROVAL= TA YEAR= 2020 NDA 209845 (pdf not found) INN (APIXABAN) APIXABAN (BRECKENRIDGE) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 210053 (pdf not found) INN (APIXABAN) APIXABAN (SIGMAPHARM LABS LLC) APPROVAL= TA YEAR= 2022 NDA 210133 (pdf not found) INN (APIXABAN) APIXABAN (PRINSTON PHARMA INC) APPROVAL= TA YEAR= 2022 NDA 213903 (pdf not found) INN (APIXABAN) APIXABAN (ZHEJIANG YONGNING PHARMACEUTICAL CO LTD) APPROVAL= TA YEAR= 2022 NDA 210026 (pdf not found) INN (APIXABAN) APIXABAN (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2023 DISCONTINUED NDA 210066 (pdf not found) INN (APIXABAN) APIXABAN (HETERO LABS LTD V) APPROVAL= AP YEAR= 2023 DISCONTINUED NDA 210185 (pdf not found) INN (APIXABAN) APIXABAN (ZYDUS PHARMS) APPROVAL= AP YEAR= 2023 DISCONTINUED NDA 210156 (pdf not found) INN (APIXABAN) APIXABAN (TORRENT) APPROVAL= AP YEAR= 2024 DISCONTINUED NDA 210091 (pdf not found) INN (APIXABAN) APIXABAN (APOTEX) APPROVAL= AP YEAR= 2024 DISCONTINUED NDA 209810 (pdf not found) INN (APIXABAN) APIXABAN (IMPAX) APPROVAL= AP YEAR= 2025 DISCONTINUED NDA 210067 (pdf not found) INN (APIXABAN) APIXABAN (MACLEODS PHARMS LTD) APPROVAL= AP YEAR= 2025 DISCONTINUED NDA 218119 (pdf not found) INN (APIXABAN) APIXABAN (SCIEGEN PHARMACEUTICALS INC) APPROVAL= TA YEAR= 2025 NDA 220073 (label) INN (APIXABAN) ELIQUIS SPRINKLE (BRISTOL) APPROVAL= AP YEAR= 2025 |
Other links: |